Related Experiment Video
Updated: Feb 16, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
Published on: October 23, 2020
Accommodating informative dropout and death: a joint modelling approach for longitudinal and semi-competing risks
This study introduces a new statistical method to analyze longitudinal health data, accounting for patient dropout and death. The approach allows accurate estimation of health trends, like CD4 counts, for living individuals in long-term studies.
Area of Science:
- Biostatistics
- Epidemiology
- Longitudinal Data Analysis
Background:
- Longitudinal studies are crucial for tracking health outcomes over time.
- Patient dropout and death can bias observed trends by removing data.
- Accurate analysis requires methods that handle these semi-competing events effectively.
Purpose of the Study:
- To develop a statistical framework for analyzing longitudinal outcomes in the presence of informative dropout and death.
- To enable the estimation of the longitudinal outcome profile conditional on survival.
- To apply the method to CD4 count data in HIV research.
Main Methods:
- A likelihood-based approach is proposed for joint modeling.
- The model incorporates longitudinal outcomes and semi-competing event times (dropout and death).
- A key feature is the closed-form derivation of the conditional longitudinal profile for living subjects.
Main Results:
- The proposed method effectively accommodates informative dropout and death.
- It allows for the estimation of the longitudinal CD4 count profile for living patients.
- The approach provides a more accurate representation of disease progression in HIV-infected individuals.
Conclusions:
- The joint modeling approach offers a robust solution for longitudinal data with semi-competing risks.
- This method enhances the understanding of disease trajectories by focusing on the alive population.
- It is particularly valuable for long-term health studies where informative censoring is common.
Related Concept Videos
Longitudinal Research
Model Approaches for Pharmacokinetic Data: Compartment Models
Two primary types of compartment models are recognized: mammillary and catenary. The more...
Model Approaches for Pharmacokinetic Data: Physiological Models
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...

